Turn Therapeutics names Redfield chief scientific officer, sets Stifel forum dateSep 10PeopleTurn Therapeutics
Turn Therapeutics expands Phase 2 atopic dermatitis trial after interim data reviewAug 12Quarterly updateTurn Therapeutics
Sign inSign in